APOB and Hyperglycemia: Other studies are consistent with these results and show that the biomarkers of hyperglycemia, hypertriglyceridemia, higher ApoA-I, and ApoB–to–ApoA-I ratio are significantly associated with T1DM risk [40,63,64,65].